Drug Target Review2024-04-30T12:00:33
The new organoids demonstrate a greater diversity of TECs in culture and are capable of maturing T cells.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2026-09-23T15:00:00
Sponsored by BioIVT
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-03-20T13:41:33
Sponsored by Bio-Techne
2026-06-09T08:20:00
Contributor Steve Smith, Drug Target Review
Site powered by Webvision Cloud